Cargando…

Radioresistance of Non-Small Cell Lung Cancers and Therapeutic Perspectives

SIMPLE SUMMARY: The poor survival of unresectable locally advanced stage non-small cell lung cancer is due to the resistance to chemoradiotherapy and local/distant relapses. However, with the advent of new drugs, it has become possible to improve the prognosis of patients with stage III NSCLC harbor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Césaire, Mathieu, Montanari, Juliette, Curcio, Hubert, Lerouge, Delphine, Gervais, Radj, Demontrond, Pierre, Balosso, Jacques, Chevalier, François
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9221493/ https://www.ncbi.nlm.nih.gov/pubmed/35740495 http://dx.doi.org/10.3390/cancers14122829

Ejemplares similares

Off-Label Use of Crizotinib as a Neoadjuvant Treatment for a Young Patient When Conventional Chemotherapy Gave No Benefits in Stage IIIA Non-Small Cell Lung Cancer
por: Dumont, Delphine, et al.
Publicado: (2017)

Safety of combined PD‐1 pathway inhibition and radiation therapy for non‐small‐cell lung cancer: A multicentric retrospective study from the GFPC
por: Lesueur, Paul, et al.
Publicado: (2018)

Stereotactic ablative radiotherapy and systemic treatments for extracerebral oligometastases, oligorecurrence, oligopersistence and oligoprogression from lung cancer
por: Kissel, Manon, et al.
Publicado: (2019)

Review: Mechanisms and perspective treatment of radioresistance in non-small cell lung cancer
por: Zhou, Ting, et al.
Publicado: (2023)

Combining PARP Inhibition, Radiation, and Immunotherapy: A Possible Strategy to Improve the Treatment of Cancer?
por: Césaire, Mathieu, et al.
Publicado: (2018)

Hadrontherapy Interactions in Molecular and Cellular Biology
por: Thariat, Juliette, et al.
Publicado: (2019)

Harmonizing SUVs in multicentre trials when using different generation PET systems: prospective validation in non-small cell lung cancer patients
por: Lasnon, Charline, et al.
Publicado: (2013)

Case Report About Fatal or Near-Fatal Hypersensitivity Reactions to Cetuximab: Anticetuximab IgE as a Valuable Screening Test
por: Dupont, Benoît, et al.
Publicado: (2014)

Chondrosarcoma Resistance to Radiation Therapy: Origins and Potential Therapeutic Solutions
por: Gilbert, Antoine, et al.
Publicado: (2023)

A randomized controlled phase III study comparing hadrontherapy with carbon ions versus conventional radiotherapy – including photon and proton therapy – for the treatment of radioresistant tumors: the ETOILE trial
por: Balosso, Jacques, et al.
Publicado: (2022)

FK228 sensitizes radioresistant small cell lung cancer cells to radiation
por: Li, Hong, et al.
Publicado: (2021)

Surmounting Chemotherapy and Radioresistance in Chondrosarcoma: Molecular Mechanisms and Therapeutic Targets
por: Onishi, Anne C., et al.
Publicado: (2011)

Purine metabolism promotes radioresistance and is a therapeutic target in glioblastoma
por: Zhou, Weihua, et al.
Publicado: (2020)

NRF2-pathway mutations predict radioresistance in non-small cell lung cancer
por: Kinslow, Connor J., et al.
Publicado: (2022)

Identification of Key Genes and FUNCTIONAL Pathway in Radioresistance of Non-Small Cell Lung Cancer
por: Li, Shouying, et al.
Publicado: (2022)

Transcriptome-Based Traits of Radioresistant Sublines of Non-Small Cell Lung Cancer Cells
por: Pustovalova, Margarita, et al.
Publicado: (2023)

Validation of an anti-α-Gal IgE fluoroenzyme-immunoassay for the screening of patients at risk of severe anaphylaxis to cetuximab
por: Serrier, Julien, et al.
Publicado: (2023)

Detection of ALK fusion transcripts in plasma of non-small cell lung cancer patients using a novel RT-PCR based assay
por: Heeke, Simon, et al.
Publicado: (2021)

Microbeam radiation therapy — grid therapy and beyond: a clinical perspective
por: Schültke, Elisabeth, et al.
Publicado: (2017)

MiR-210 promotes a hypoxic phenotype and increases radioresistance in human lung cancer cell lines
por: Grosso, S, et al.
Publicado: (2013)

CSC Radioresistance: A Therapeutic Challenge to Improve Radiotherapy Effectiveness in Cancer
por: Olivares-Urbano, María Auxiliadora, et al.
Publicado: (2020)

Treatment of Radioresistant Cancers
por: Hendry, J. H.
Publicado: (1980)

Radioresistance of Brain Tumors
por: Kelley, Kevin, et al.
Publicado: (2016)

Exosomes in Cancer Radioresistance
por: Ni, Jie, et al.
Publicado: (2019)

Tumor microenvironment and radioresistance
por: Suwa, Tatsuya, et al.
Publicado: (2021)

Evaluation of the role of mir-34b in modulation of radioresistance in non-small cell lung cancer
por: Silva, Joana B, et al.
Publicado: (2010)

Stathmin1 increases radioresistance by enhancing autophagy in non-small-cell lung cancer cells
por: Zhang, Xi, et al.
Publicado: (2016)

The Diverse Analysis Identifies Mutated KRAS Associated With Radioresistance in Non-Small Cell Lung Cancer
por: Zhu, Dao Qi, et al.
Publicado: (2022)

The Molecular and Cellular Strategies of Glioblastoma and Non-Small-Cell Lung Cancer Cells Conferring Radioresistance
por: Alhaddad, Lina, et al.
Publicado: (2022)

Octogenarians with EGFR-mutated non-small cell lung cancer treated by tyrosine-kinase inhibitor: a multicentric real-world study assessing tolerance and efficacy (OCTOMUT study)
por: Corre, Romain, et al.
Publicado: (2018)

Metabolic analysis of radioresistant medulloblastoma stem-like clones and potential therapeutic targets
por: Sun, Lue, et al.
Publicado: (2017)

A New Generation of Ultrasmall Nanoparticles Inducing Sensitization to Irradiation and Copper Depletion to Overcome Radioresistant and Invasive Cancers
por: Rocchi, Paul, et al.
Publicado: (2022)

Downregulation of ubiquitin inhibits the proliferation and radioresistance of non-small cell lung cancer cells in vitro and in vivo
por: Tang, Yiting, et al.
Publicado: (2015)

Plasminogen activator inhibitor-1 enhances radioresistance and aggressiveness of non-small cell lung cancer cells
por: Kang, JiHoon, et al.
Publicado: (2016)

RKIP reduction enhances radioresistance by activating the Shh signaling pathway in non-small-cell lung cancer
por: Xie, Shi-Yang, et al.
Publicado: (2017)

Selection of Radioresistant Cells by Vitamin A Deficiency in a Small Cell Lung Cancer Cell Line
por: Terasaki, Takeo, et al.
Publicado: (1990)

SOX2 Promotes Radioresistance in Non-small Cell Lung Cancer by Regulating Tumor Cells Dedifferentiation
por: Wang, Shennan, et al.
Publicado: (2023)

Suppresses of LIM kinase 2 promotes radiosensitivity in radioresistant non-small cell lung cancer cells
por: Tian, Chao, et al.
Publicado: (2023)

Contribution of the Idylla(TM) System to Improving the Therapeutic Care of Patients with NSCLC through Early Screening of EGFR Mutations
por: Petiteau, Constance, et al.
Publicado: (2021)

Dosimetrical and radiobiological approach to manage the dosimetric shift in the transition of dose calculation algorithm in radiation oncology: how to improve high quality treatment and avoid unexpected outcomes?
por: Chaikh, Abdulhamid, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_rmcbqsrtkakj2ff4pk3oaqlv1u